Cargando…
Exploring the plasmatic platelet-activating factor acetylhydrolase activity in patients with anti-phospholipid antibodies
PURPOSE: To explore the role of plasmatic platelet-activating factor acetylhydrolase (PAF-AH), a marker of cardiovascular risk, in patients with anti-phospholipid antibodies (aPL). METHODS: PAF-AH activity was assessed in a series of 167 unselected patients screened for aPL in a context of thromboti...
Autores principales: | Fabris, Martina, Cifù, Adriana, Pistis, Cinzia, Siega-Ducaton, Massimo, Fontana, Desrè Ethel, Giacomello, Roberta, Tonutti, Elio, Curcio, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365449/ https://www.ncbi.nlm.nih.gov/pubmed/28341873 http://dx.doi.org/10.1007/s13317-017-0092-7 |
Ejemplares similares
-
The introduction of anti-phosphatidylserine/prothrombin autoantibodies in the laboratory diagnostic process of anti-phospholipid antibody syndrome: 6 months of observation
por: Fabris, Martina, et al.
Publicado: (2014) -
Platelets and platelet-activating factor acetylhydrolase in septic patients
por: Ruβwurm, S, et al.
Publicado: (1999) -
Platelet-activating factor acetylhydrolase and haemophagocytosis in the sepsis syndrome.
por: Trimoreau, F, et al.
Publicado: (2000) -
Platelet-activating factor acetylhydrolase in primary antiphospholipid syndrome
por: Ames, Paul R. J., et al.
Publicado: (2018) -
Platelet-activating factor acetylhydrolase and transacetylase activities in human aorta and mammary artery
por: Tsoukatos, Demokritos C., et al.
Publicado: (2008)